LJUBLJANA, March 2 (Reuters) - Generic drug producer Krka
KRKG.LJ , Slovenia's largest listed company, reported a 31.5
percent fall in 2016 group net profit on Thursday despite a rise
in sales.
Net profit fell to 108.4 million euros ($114.1 million) from
158.2 million while sales advanced to 1.17 billion euros from
1.16 billion, it said in a statement.
($1 = 0.9500 euros)
(Reporting by Marja Novak and Maja Zuvela; editing by Jason
Neely)
((maja.zuvela@thomsonreuters.com; +387 33 295 485; Reuters
Messaging: maja.zuvela.thomsonreuters.com@reuters.net))
Keywords: KRKA RESULTS/